Takayuki Kanaseki

Professor

Niigata University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Takayuki Kanaseki is a Professor at Niigata University in Japan. His research encompasses immunology and cancer therapy, with recent articles focusing on T cell responses, neoantigens, and the tumor microenvironment in various types of cancer. His work includes the development of novel immunotherapeutic targets and strategies, particularly in relation to oral cancer and endometrial cancer.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (2)

Minami Fusagawa

Sapporo Medical University

JAPAN

View details

Sho Miyamoto

Assistant Professor

School of Dentistry, Health Sciences University of Hokkaido

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takayuki Kanaseki

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer

Effect of human survivin‐2B‐specific cytotoxic CD8+ T lymphocytes on CD44+/− HSC‐2 and HSC‐3 oral cancer cells

Loss of Tapasin in Tumors Potentiates T‐Cell Recognition and Anti‐Tumor Effects of Immune Checkpoint Blockade

Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment

Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes

Development of T cell receptor‐engineered T cells targeting the sarcoma‐associated antigen papillomavirus binding factor

Exploring olfactory receptor family 7 subfamily C member 1 as a novel oral cancer stem cell target for immunotherapy

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma

Cisplatin‐induced HSF1‐HSP90 axis enhances the expression of functional PD‐L1 in oral squamous cell carcinoma

Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer

Collaborators (2)

Minami Fusagawa

Sho Miyamoto

Make your next move.